Webinar
Nutrition As The Keystone to Success During GLP-1 Treatment
View all IQVIA events

IQVIA Consumer Health experts Dr. Volker Spitzer, Sarah Rickwood and Matt Stewart explore the rapidly evolving landscape of obesity management and the expanding impact of GLP-1 therapies.

As these breakthrough treatments move into the mainstream, the discussion focuses on nutrition in obesity care — the critical, and often overlooked, factor that supports long-term patient outcomes, treatment success, and sustainable health results.

Key discussions you won’t want to miss

  • GLP-1 therapies at scale: How easing shortages and improving access are reshaping the obesity-treatment market.
  • Nutrition as the differentiator: Bridging the gap between medication efficacy and sustainable results through evidence-based nutrition.
  • Addressing nutrient deficits: Closing protein, fibre, and micronutrient gaps in GLP-1 users to enhance clinical and commercial outcomes.
  • The first 90 days for patient success: The critical role of early nutrition support and adherence in driving long-term results.
  • Innovation and collaboration: How pharma, OTC, and nutrition brands can co-create validated, personalized solutions for GLP-1 patients.
See video timecodes below:

00:42 – The changing landscape of obesity Care
How the end of GLP-1 shortages and growing access in 2025 are transforming obesity management at scale.

02:10 – Nutrition’s expanding role in GLP-1 therapy success
Exploring why structured nutrition guidance is essential to maintain results and manage long-term adherence.

04:35 – Evidence on nutrient intake in GLP-1 users
Data showing reduced calorie and micronutrient consumption — and how nutrient-dense foods and supplements can help address these gaps.

06:20 – Micronutrients to monitor
Key focus areas including B12, iron, calcium, vitamin D and magnesium — and why proactive monitoring supports safety and persistence..

08:05 – Evidence-based nutrition targets
Best-practice data on protein, fibre, hydration, and supplementation — and how these support metabolic stability.

10:40 – Integrating nutrition into care pathways
Practical frameworks for healthcare professionals to pair pharmacotherapy with structured nutrition and follow-up.

13:10 – Opportunities for nutrition innovation
Opportunities for the medical and food industries to develop nutrient-dense, high-protein products tailored for GLP-1 users.

16:00 – The role of pharmacies and digital support
How digital tools, pharmacies, and refill models are helping track adherence and sustain outcomes during GLP-1 therapy.

18:20 – Practical framework for nutrition support
Key components of the “Screen–Plan–Supplement–Strengthen” model and the importance of regular touchpoints.

20:10 – Closing insights and best practice
Summary of data-led next steps for healthcare, nutrition, and pharmacy partners to improve long-term outcomes.

You can download the full transcript here.

Want to explore how nutrition strategies can enhance GLP-1 treatment outcomes? Connect with our experts to learn how IQVIA Consumer Health can support your next initiative.

 

Explore our resources on nutrition’s role in GLP-1 therapy

Nutrition as the Keystone for Obesity Management Medication – Whitepaper

Gain expert insights into the nutritional implications of GLP-1 therapies and their impact on obesity management. Explore how nutrition influences patient outcomes, supports long-term success, and creates new opportunities for growth in obesity care.

Nutrition As The Keystone to Success During GLP-1 Treatment – Slides

Review the slides from our expert discussion covering the changing landscape of obesity care, nutrient shortfalls in GLP-1 users, the first 90 days of therapy, and opportunities for innovation across the health and nutrition ecosystem.

Partner with us on GLP-1 and nutrition
Whether you’re exploring opportunities in GLP-1 therapies, clinical nutrition or broader obesity-care innovation, our experts can help turn data into evidence and action.

Related solutions

Contact Us